METHODS OF TREATING CANCER COMPRISING TARGETING NQO1
申请人:BOOTHMAN David
公开号:US20130253046A1
公开(公告)日:2013-09-26
Disclosed herein are methods for determining whether an individual with cancer is suitable for a treatment with an NQO1 bioactivatable drug, predicting responsiveness of an individual with cancer to a treatment with an NQO1 bioactivatable drug, and treating an individual with cancer with an NQO1 bioactivatable drug composition.
US9469878B2
申请人:——
公开号:US9469878B2
公开(公告)日:2016-10-18
US9631041B2
申请人:——
公开号:US9631041B2
公开(公告)日:2017-04-25
[EN] PH-SENSITIVE COMPOSITIONS FOR DELIVERY OF BETA LAPACHONE AND METHODS OF USE<br/>[FR] COMPOSITIONS SENSIBLES AU PH POUR ADMINISTRATION DE BÊTA-LAPACHONE ET LEURS PROCÉDÉS D'UTILISATION
申请人:UNIV TEXAS
公开号:WO2012039855A1
公开(公告)日:2012-03-29
Disclosed herein are compounds comprising a polymer conjugated with a pH-sensitive prodrug of beta-lapachone, wherein the compound is capable of forming a micelle, and wherein the pH-sensitive prodrug comprises a pH-sensitive linker selected from the group consisting of: an aryl imine and an aliphatic imine. Also provided are micelles comprised of such polymer-prodrug conjugates. Further provided are methods for treating cancer with the micelles.